AAAAAA

   
Results: 1-20 |
Results: 20
Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice
Authors: Sidwell, RW Smee, DF Bailey, KW Burger, RA
Citation: Rw. Sidwell et al., Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice, INT IMMUNO, 1(6), 2001, pp. 1211-1218
Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201
Authors: Smee, DF Sidwell, RW Morrison, AC Bailey, KW Baum, EZ Ly, L Wagaman, PC
Citation: Df. Smee et al., Characterization of an influenza A (H3N2) virus resistant to the cyclopentane neuraminidase inhibitor RWJ-270201, ANTIVIR RES, 52(3), 2001, pp. 251-259
Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice
Authors: Smee, DF Bailey, KW Wong, MH Sidwell, RW
Citation: Df. Smee et al., Effects of cidofovir on the pathogenesis of a lethal vaccinia virus respiratory infection in mice, ANTIVIR RES, 52(1), 2001, pp. 55-62
Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201
Authors: Sidwell, RW Smee, DF Huffman, JH Barnard, DL Morrey, JD Bailey, KW Feng, WC Babu, YS Bush, K
Citation: Rw. Sidwell et al., Influence of virus strain, challenge dose, and time of therapy initiation on the in vivo influenza inhibitory effects of RWJ-270201, ANTIVIR RES, 51(3), 2001, pp. 179-187
Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor,in a lethal murine model of influenza predicts efficacy for once-daily dosing
Authors: Drusano, GL Preston, SL Smee, D Bush, K Bailey, K Sidwell, RW
Citation: Gl. Drusano et al., Pharmacodynamic evaluation of RWJ-270201, a novel neuraminidase inhibitor,in a lethal murine model of influenza predicts efficacy for once-daily dosing, ANTIM AG CH, 45(7), 2001, pp. 2115-2118
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities
Authors: Smee, DF Huffman, JH Morrison, AC Barnard, DL Sidwell, RW
Citation: Df. Smee et al., Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities, ANTIM AG CH, 45(3), 2001, pp. 743-748
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201
Authors: Sidwell, RW Smee, DF Huffman, JH Barnard, DL Bailey, KW Morrey, JD Babu, YS
Citation: Rw. Sidwell et al., In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201, ANTIM AG CH, 45(3), 2001, pp. 749-757
Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus
Authors: Song, GY Paul, V Choo, H Morrey, J Sidwell, RW Schinazi, RF Chu, CK
Citation: Gy. Song et al., Enantiomeric synthesis of D- and L-cyclopentenyl nucleosides and their antiviral activity against HIV and West Nile virus, J MED CHEM, 44(23), 2001, pp. 3985-3993
Prenatal viral infection causes alterations in nNOS expression in developing mouse brains
Authors: Fatemi, SH Cuadra, AE El-Fakahany, EE Sidwell, RW Thuras, P
Citation: Sh. Fatemi et al., Prenatal viral infection causes alterations in nNOS expression in developing mouse brains, NEUROREPORT, 11(7), 2000, pp. 1493-1496
Spectrum of virus inhibition by consensus interferon YM643
Authors: Yasuda, S Huffman, JH Smee, DF Sidwell, RW Miyata, K
Citation: S. Yasuda et al., Spectrum of virus inhibition by consensus interferon YM643, ANTIVIR CHE, 11(5), 2000, pp. 337-341
Treatment of cowpox virus respiratory infections in mice with ribavirin asa single agent or followed sequentially by cidofovir
Authors: Smee, DF Bailey, KW Sidwell, RW
Citation: Df. Smee et al., Treatment of cowpox virus respiratory infections in mice with ribavirin asa single agent or followed sequentially by cidofovir, ANTIVIR CHE, 11(4), 2000, pp. 303-309
In vitro and in vivo assay systems for study of influenza virus inhibitors
Authors: Sidwell, RW Smee, DF
Citation: Rw. Sidwell et Df. Smee, In vitro and in vivo assay systems for study of influenza virus inhibitors, ANTIVIR RES, 48(1), 2000, pp. 1-16
Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir
Authors: Smee, DF Bailey, KW Wong, MH Sidwell, RW
Citation: Df. Smee et al., Intranasal treatment of cowpox virus respiratory infections in mice with cidofovir, ANTIVIR RES, 47(3), 2000, pp. 171-177
Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice
Authors: Burger, RA Billingsley, JL Huffman, JH Bailey, KW Kim, CU Sidwell, RW
Citation: Ra. Burger et al., Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice, IMMUNOPHARM, 47(1), 2000, pp. 45-52
Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice
Authors: Fatemi, SH Emamian, ES Kist, D Sidwell, RW Nakajima, K Akhter, P Shier, A Sheikh, S Bailey, K
Citation: Sh. Fatemi et al., Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice, MOL PSYCHI, 4(2), 1999, pp. 145-154
Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine
Authors: Morrey, JD Bailey, KW Korba, BE Sidwell, RW
Citation: Jd. Morrey et al., Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine, ANTIVIR RES, 42(2), 1999, pp. 97-108
2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection
Authors: Barnard, DL Sidwell, RW Xiao, W Player, MR Adah, SA Torrence, PF
Citation: Dl. Barnard et al., 2-5A-DNA conjugate inhibition of respiratory syncytial virus replication: effects of oligonucleotide structure modifications and RNA target site selection, ANTIVIR RES, 41(3), 1999, pp. 119-134
Resistance to friend leukemia virus in transgenic mice expressing the native FV-4 gene
Authors: Jackson, MK Mitchell, EA Winslow, SG Okelberry, KM Sidwell, RW Morrey, JD
Citation: Mk. Jackson et al., Resistance to friend leukemia virus in transgenic mice expressing the native FV-4 gene, ACT VIROLOG, 43(1), 1999, pp. 19-23
Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.
Authors: Tai, CY Escarpe, PA Sidwell, RW Williams, MA Lew, W Wu, HW Kim, CU Mendel, DB
Citation: Cy. Tai et al., Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071., ANTIM AG CH, 42(12), 1998, pp. 3234-3241
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection
Authors: Morrey, JD Korba, BE Sidwell, RW
Citation: Jd. Morrey et al., Transgenic mice as a chemotherapeutic model for hepatitis B virus infection, THERAPIES FOR VIRAL HEPATITIS, 1998, pp. 161-170
Risultati: 1-20 |